Birc5 was a potential biomarker and inducer of intratumor infiltration of MDSCs, which led to T‐cell exclusion or dysfunction in tumor immune microenvironment, consequently resulting in reduced response to ICIs in HCC. The gene discussed is BIRC5; the disease is neoplasm.